Akso Health Group (AHG) Stock Price & Analysis

Akso Health Group (AHG) closed at USD 1.22 on Thursday, October 22, 2026, down 3.94% on the day. The US market is currently closed (pre-market); this is not a live price.

The prior close was USD 1.27; the Oct 22, 2026 session ranged USD 1.21–1.29 on volume of 7,036 shares. Market capitalization is $1.05B, with a 52-week range of USD 0.68–2.5 (NCM). Source: Nexqual, retrieved October 23, 2026 at 09:59 UTC.

Also available as compact Markdown for AI agents: nexqual.com/AHG.md

Key facts (AHG)

Analysts (AHG)

Consensus None.

Total return (dividends reinvested) (AHG)

1Y (from 2025-10-23)5Y (from 2021-10-18)
Total return-27.4%-78.3%
S&P 500 (SPY)+14.9%+80.3%
Per year-27.5%-26.3%
Volatility (annualized)93.3%114.6%
Max drawdown-72.4% (Mar 2026→Sep 2026)-95.2% (Oct 2021→Jul 2023)

AHG analyst estimates and revisions

PeriodEPS estimate90 days agoChangeRevenue estimateAnalysts
Current quarter (ends Sep 2019)———$0—
Next quarter———$0—
Current fiscal year (ends Mar 2020)———$0—
Next fiscal year———$0—

Key Statistics (as of October 23, 2026 at 09:59 UTC)

PriceUSD 1.22
Change▼ 3.94% (down)
Previous CloseUSD 1.27
OpenUSD 1.23
Day RangeUSD 1.21 – 1.29
52-Week RangeUSD 0.68 – 2.5
Volume7,036 shares
Market Cap$1.05B
ExchangeNCM

Technical Analysis (AHG)

Nexqual's technical model rates AHG "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 23, 2026 at 09:59 UTC.

Overall SignalSTRONG BUY
RSI (14)57.08 (neutral)
vs SMA50Above (USD 1)
MACD0.1 (positive)

Analyst Ratings (AHG)

Wall Street analysts rate AHG "None", per Nexqual as of October 23, 2026 at 09:59 UTC.

Consensus RatingNone

Earnings (AHG)

Recent Earnings History

QuarterActual vs Estimate
2019-06-30USD -0.45 vs est 0 ▼ miss
2019-03-31USD 0.15 vs est -0.3 ▲ beat
2018-12-31USD -0.6 vs est -0.78 ▲ beat

Source: Nexqual, October 23, 2026 at 09:59 UTC.

Financials & Fundamentals (AHG)

Total Revenue$13.83M
Revenue Growth (latest quarter, YoY)-12.90%
Gross Margin-0.08%
Operating Margin-37.50%
Profit Margin-134.99%
ROE-9.85%
Debt / Equity0.01
Current Ratio21.77
Total Cash$170,572
Total Debt$2.38M

Source: Nexqual, October 23, 2026 at 09:59 UTC.

Financial Health Score (AHG)

Nexqual rates Akso Health Group's overall financial health "Weak" across five dimensions, as of October 23, 2026 at 09:59 UTC.

GrowthCritical — Revenue -43% YoY (annual), sharp decline
ProfitabilityCritical — Gross margin -0%, operating -38% (last 12 months)
Balance SheetStrong — $171K cash vs $2M debt
Cash FlowWeak — Operating cash flow -$13M (TTM)
EfficiencyCritical — ROE -10%, ROA -1.2%

Ownership (AHG)

Insider Ownership+0.00%
Institutional Ownership+0.03%
Shares Outstanding854.04M
Float854.05M
Short % of Float+0.00%

Source: Nexqual, October 23, 2026 at 09:59 UTC.

Leadership (AHG)

Akso Health Group is led by Yilin Wang, CEO & Chairwoman of the Board, per Nexqual as of October 23, 2026 at 09:59 UTC.

CEO & Chairwoman of the BoardYilin Wang
Chief Financial OfficerZhongliang Xie

Peers & Related Stocks

SymbolNamePriceChange
HSICHenry Schein, Inc.USD 86▲ 1.16%
CAHCardinal Health, Inc.USD 255.64▼ 0.71%
CORCencora, Inc.USD 338.48▼ 0.57%
MCKMcKesson CorporationUSD 1,012.34▼ 0.31%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:59 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt